Pacira BioSciences (PCRX) Change in Cash (2010 - 2026)

Pacira BioSciences' Change in Cash history runs 17 years deep, the most recent figure standing at -$14.2 million for Q1 2026.

• In Q1 2026, Change in Cash fell 308.29% year-over-year to -$14.2 million; the TTM figure through Mar 2026 stood at -$139.3 million (down 239.92% YoY), while the FY2025 annual figure was -$118.2 million, down 195.75% from the prior year.
• Change in Cash was -$14.2 million for Q1 2026 at Pacira BioSciences, down from $11.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $63.0 million in Q2 2024 to a low of -$358.8 million in Q1 2022.
• Historically, Change in Cash has averaged -$26.0 million across 5 years, with a median of $6.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Change in Cash jumped 1125.15% in 2023, then slumped 13952.85% in 2025.
• A 5-year view of Change in Cash shows it stood at -$5.3 million in 2022, then surged by 1125.15% to $54.2 million in 2023, then plunged by 43.13% to $30.8 million in 2024, then sank by 64.44% to $11.0 million in 2025, then plunged by 229.97% to -$14.2 million in 2026.
• The last three Change in Cash figures came in at -$14.2 million (Q1 2026), $11.0 million (Q4 2025), and -$152.9 million (Q3 2025), per Business Quant data.